Login / Signup

Efficacy and safety of belimumab therapy in systemic lupus erythematosus: A systematic review and meta-analysis.

Hsin-Yu ChiangZi-An GuoTa-Wei WuTzu-Rong Peng
Published in: Lupus (2022)
The results suggest that belimumab plus standard therapy is more effective than placebo plus standard therapy in SLE patients.
Keyphrases
  • systemic lupus erythematosus
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • clinical trial
  • randomized controlled trial
  • cell therapy
  • bone marrow
  • open label